Welcome to our dedicated page for Teradyne SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Teradyne, Inc. filings document an operating company with common stock traded on Nasdaq under TER and businesses in automated test equipment and advanced robotics. Form 8-K reports cover quarterly operating and financial results across Semiconductor Test, Product Test, and Robotics, along with material events such as annual meeting vote results and executive-transition or compensation arrangements.
Proxy materials describe board elections, advisory compensation votes, auditor ratification, executive compensation, equity-award reporting, and related governance matters. The filings also provide capital-structure details, including Teradyne's common stock class, and formal exhibits tied to earnings releases and other disclosure events.
Teradyne, Inc. executive Shannon John Poulin reported a mix of option exercises, tax withholding, and share sales in company stock. On May 21, 2026, he exercised stock options for 2,843 shares of common stock at an exercise price of $82.61 per share, then 1,531 shares were disposed of to cover the option exercise price and related tax-withholding obligations. Also on May 21, 2026, he sold 1,008 shares in open-market transactions at $345.37 per share, followed by an additional sale of 656 shares at $355.00 per share on May 22, 2026. The filing states that the sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 19, 2026, and after these transactions he directly holds approximately 15,722 shares of Teradyne common stock.
Teradyne, Inc. director Marilyn Matz reported an open-market sale of company common stock. On May 21, 2026, she sold 400 shares of Teradyne common stock at $350 per share. After this transaction, she directly holds 18,640.675 shares of common stock. The filing notes that this sale was executed under a pre-arranged sales plan adopted on February 13, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
TER Rule 144 notice: a holder reported intended sale of 656 shares via a stock option exercise on 05/21/2026, with the method listed as cash. The filing also records 1,008 shares sold in the prior three months for $348,132.96.
TER: A Form 144 notice reports proposed and recent insider-related transactions in common stock. The filing lists 400 shares identified as "Securities To Be Sold" tied to Restricted Stock Vesting with a date of 05/08/2026. It also records that Marilyn Matz sold 800 shares on 05/15/2026 for $271,184.00. Broker details include Fidelity Brokerage Services LLC and a reporting date of 05/21/2026.
Teradyne, Inc. President and CEO Gregory Stephen Smith exercised stock options for 4,597 shares of common stock at $72.10 per share and sold 8,597 shares at $338.98 per share. After these transactions, he directly holds 124,469.5729 common shares. The trades were executed under a pre-arranged Rule 10b5-1 sales plan adopted on February 12, 2026.
Teradyne director Marilyn Matz sold 800 shares of common stock at $338.98 per share in an open-market transaction. After this sale, she directly holds 19,040.675 shares. The trade was carried out under a pre-arranged Rule 10b5-1 sales plan adopted on February 13, 2026.
TER submitted a Form 144 notice to sell 8,597 shares of Common Stock via Fidelity Brokerage Services LLC. The filing lists specific sale/vesting events tied to restricted stock vesting on 01/28/2026 and 02/01/2026, and an options-related item dated 05/15/2026. The filing names NASDAQ as the market and references cash proceeds for the options‑related item.
Herweck Peter reported acquisition or exercise transactions in this Form 4 filing.
Teradyne, Inc. director Peter Herweck received a grant of 668 restricted stock units (RSUs) of Common Stock. The award was granted under Teradyne's 2006 Equity and Cash Compensation Incentive Plan as a form of equity compensation rather than a cash purchase.
Each RSU represents the right to receive one share of Common Stock. The RSUs are time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne's 2027 Annual Meeting of Shareholders. After this grant, Herweck directly holds 16,134 shares of Common Stock.